Next, the upregulation of TRA2A in HCC cell lines was validated (Supplementary Figure S2F), and sh-1# was selected for subsequent functional experiments after determining the transfection efficiency (Supplementary Figure S2G, H). The gene discussed is TRA2A; the disease is hepatocellular carcinoma.